Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: A case series

American Journal of Hematology

Volumn 83, Issue 6, 2008, Pages 508-511

  Bestawros, Alain ^a   Michel, René ^b   Séguin, Chantal ^a   Routy, Jean Pierre ^b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; CORTICOSTERONE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; PREDNISONE; RITUXIMAB; STAVUDINE; VINCRISTINE;

ADULT; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMORBIDITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEVER; GASTROINTESTINAL SYMPTOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; GIANT LYMPH NODE HYPERPLASIA; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL PROTEINS;

EID: 44349092406     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21108     Document Type: Article

References (19)

1. Castleman B, Iverson L, Menedez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956;9:822-830.
2. Gaba AR, Stein RS, Sweet DL, et al. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86-90.
3. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric CD. Blood 1995;86:1276-1280.
4. Cannon JS, Nicholas J, Orenstein JM, et al. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis 1999;180:824-828.
5. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 1999;93:4034-4043.
6. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002;99:2331-2336.
7. Andres E, Maloisel F. Interferon-α as first-line therapy for treatment of multicentric Castleman's disease. Ann Oncol 2000;11:1613-1614.
8. Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 2005;106:2627-2632.
9. Marcelin AG, Aaron L, Mateus C, et al. Rituximab therapy for HIV-associated Castleman disease. Blood 2003;102:2786-2788.
10. Corbellino M, Bestetti G, Scalamogna C, et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 2001;98:3473-3475.
11. Neuville S, Agbalika F, Rabian C, et al. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease. Am J Hematol 2005;79:337-339.
12. Gérard L, Bérezné A, Galicier L, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease : ANRS 117 Castleman trial. J Clin Oncol 2007;25:3350-3356.
13. Casper C, Nichols WG, Huang M-L. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 2004; 103:1632-1634.
14. Casper C, Wald A. The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma. Curr Top Microbiol Immunol 2007;312:289-307.
15. Scott D, Cabral L, Harrington WJ Jr. Treatment of HIV-associated multicentric Castleman's disease with oral etoposide. Am J Hematol 2001;66:148-150.
16. Colleoni GW, Duarte LC, Kerbauy FR, et al. 2-Chloro-deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non-Hodgkin's lymphoma. Acta Oncol 2003;42:784-787.
17. Starkey CR, Joste NE, Lee FC. Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide. Am J Hematol 2006;81:303-304.
18. Chronowski GM, Ha CS, Wilder RB, et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001;92:670-676.
19. Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998;128:657-662.